Clinical trial
Prospective Comparative Effectiveness Trial of Carbon Ion Therapy, Surgery, and Proton Therapy for the Management of Pelvic Sarcomas (Soft Tissue/Bone) Involving the Bone
NCT05033288 is registered in ClinicalTrials.gov with Mayo Clinic as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Prospective Comparative Effectiveness Trial of Carbon Ion Therapy, Surgery, and Proton Therapy for the Management of Pelvic Sarcomas (Soft Tissue/Bone) Involving the Bone
- Lead sponsor
- Mayo Clinic
- Phase
- Observational
- Overall status
- Recruiting
- Start date
- January 20, 2022
- Completion date
- August 30, 2031
- Enrollment
- 72 (estimated)
- Sites
- 3
Conditions
As the registry lists them; a condition with its own page is linked.
bone sarcoma, chondrosarcoma, chordoma, ewing sarcoma of bone, pelvic rhabdomyosarcoma